• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,200.68 -893.39
( -1.16%)
Global Indices
Nasdaq
51,748.06 162.36
(0.31%)
Dow Jones
7,496.17 -25.41
(-0.34%)
Hang Seng
70,132.76 -2,221.20
(-3.07%)
Nikkei 225
10,441.93 78.66
(0.76%)
Forex
USD-INR
94.32 -0.07
(-0.07%)
EUR-INR
108.15 -0.25
(-0.23%)
GBP-INR
124.70 -0.38
(-0.31%)
JPY-INR
0.58 0.00
(-0.32%)

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530019
INE700A01033
145.1556811
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JUBLPHARMA
486.04
15252.98
EPS(TTM)
Face Value()
Div & Yield %
1.97
1
0.52
 

Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter
May 25,2026
Net profit of Fredun Pharmaceuticals rose 56.58% to Rs 11.07 crore in the quarter ended March 2026 as against Rs 7.07 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 59.59% to Rs 33.21 crore in the year ended March 2026 as against Rs 20.81 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales210.41165.44 27 633.33451.71 40
OPM %13.8510.54 -14.9712.20 -
PBDT14.659.29 58 55.5032.72 70
PBT11.548.04 44 47.5928.27 68
NP11.077.07 57 33.2120.81 60